Ultragenyx Pharmaceutical Inc. (RARE)

Home
RARE
Financials

39.34 (USD) • At close March 14, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Operating Activities:
Net Income Numbers are in millions	-569.183	-606.639	-707.421	-454.025	-186.566	-402.727	-197.611	-302.139	-245.874	-145.618	-59.802	-35.07	-16.334	-6.849
Depreciation & Amortization Numbers are in millions	35.543	26.006	18.22	13.239	12.261	8.539	19.538	5.825	3.424	1.384	0.684	0.444	0.313	0.034
Deferred Income Tax Numbers are in millions	0	-1.619	-1.639	48.669	-169.776	-18.939	-167.654	-16.246	6.164	0	0	0	0	0.013
Stock Based Compensation Numbers are in millions	158.03	135.213	130.377	104.952	85.735	81.995	80.107	68.014	48.309	24.884	5.394	0.657	0.891	0.254
Change In Working Capital Numbers are in millions	0	-15.101	60.235	-63.236	104.663	-15.943	-24.79	-20.231	26.302	7.736	2.166	-1.545	2.324	0.453
Accounts Receivables Numbers are in millions	-33.598	-22.778	-12.068	-5.432	9.84	-20.104	-7.583	-5.172	0	0	0	0	0	0
Inventory Numbers are in millions	-11.207	-6.93	-9.701	-3.117	-1.346	-4.451	-5.283	-0.757	0	0	0	0	0	0
Accounts Payables Numbers are in millions	46.992	2.38	87.442	2.805	29.601	20.648	3.372	3.459	2.502	-1.982	3.177	0.237	0.858	0.252
Other Working Capital Numbers are in millions	0	12.227	-5.438	-57.492	66.568	-12.036	-15.296	-23.69	23.8	9.718	-1.011	-1.782	1.466	0.201
Other Non Cash Items Numbers are in millions	-38.578	-12.666	119.763	11.706	21.463	1.692	-0.156	10.934	0.7	5.637	6.924	4.314	0.302	0.27
Operating Cash Flow Numbers are in millions	-414.188	-474.806	-380.465	-338.695	-132.22	-345.383	-290.566	-253.843	-160.975	-105.977	-44.634	-31.2	-12.504	-5.825
Investing Activities:
Investments In Property Plant And Equipment Numbers are in millions	-7.491	-44.267	-146.123	-73.093	-43.905	-24.832	-4.076	-2.793	-10.188	-4.955	-2.149	-0.407	-1.091	-0.548
Acquisitions Net Numbers are in millions	0	0	-75.025	0	0	-11.793	0	-142.804	0	0	0	0	0	0
Purchases Of Investments Numbers are in millions	-408.613	-526.382	-614.735	-1,012.187	-850.299	-707.163	-509.796	-230.487	-442.49	-624.226	-208.972	-63.953	0	0
Sales Maturities Of Investments Numbers are in millions	413.272	746.197	545.075	890.85	720.638	718.956	310.219	431.566	543.795	338.371	87.974	16.601	0	0
Other Investing Activites Numbers are in millions	-14.936	-7.548	-0.844	-0.942	-5.555	11.793	170.322	0.934	-1.202	-1.541	-0.293	0.025	-0.1	-0.376
Investing Cash Flow Numbers are in millions	-17.768	168	-291.652	-195.372	-179.121	-13.039	-33.331	56.416	89.915	-292.351	-123.44	-47.734	-1.191	-0.924
Financing Activities:
Debt Repayment Numbers are in millions	0	0	0	0	0	0	0	-4.944	0	0	0	0	0.1	2.45
Common Stock Issued Numbers are in millions	380.983	379.755	10.813	78.943	511.215	355.243	309.025	131.96	79.486	467.573	189.317	0.171	0.131	0
Common Stock Repurchased Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Dividends Paid Numbers are in millions	0	0	0	0	0	0	0	0	0	0	-4.346	0	0	0
Other Financing Activities Numbers are in millions	18.258	8.387	501.208	39.609	89.057	324.063	27.828	9.251	59.19	6.437	0.736	0	89.009	14.879
Financing Cash Flow Numbers are in millions	399.241	388.142	501.208	118.552	600.272	679.306	336.853	136.267	138.676	467.573	184.971	0.171	89.24	17.329
Other Information:
Effect Of Forex Changes On Cash Numbers are in millions	-2.525	0.462	-1.075	-1.194	1.119	-0.165	-0.472	0.528	-0.065	0	0	0	0	0
Net Change In Cash Numbers are in millions	-35.24	81.798	-171.984	-416.709	290.05	320.719	12.484	-60.632	67.551	69.245	16.897	-78.763	75.545	10.58
Cash At End Of Period Numbers are in millions	184.159	219.399	137.601	309.585	726.294	436.244	115.525	100.488	161.12	93.569	24.324	7.427	86.19	10.645

Ultragenyx Pharmaceutical Inc.

NASDAQ:RARE Add to watchlist

NASDAQ:RARE